Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets.
about
H5N1 viruses and vaccinesConfronting potential influenza A (H5N1) pandemic with better vaccinesThe generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic typesMultivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and miceA contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virusEnhanced immunogenicity, mortality protection, and reduced viral brain invasion by alum adjuvant with an H5N1 split-virion vaccine in the ferretIntranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challengeEvaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunizationCross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccineImmunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus.Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.Animal models in influenza vaccine testing.Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.Development of a vaccine against pandemic influenza viruses: current status and perspectives.Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains.A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice.A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models.Animal models for the preclinical evaluation of candidate influenza vaccines.A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferretsProtective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particlesImpact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferretsContemporary seasonal influenza A (H1N1) virus infection primes for a more robust response to split inactivated pandemic influenza A (H1N1) Virus vaccination in ferretsA novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodiesA computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferretsStockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection.The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.Evaluation of the efficacy of a pre-pandemic H5N1 vaccine (MG1109) in mouse and ferret models.Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model.Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets.B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variantConstruction of a highly efficient CRISPR/Cas9-mediated duck enteritis virus-based vaccine against H5N1 avian influenza virus and duck Tembusu virus infectionA single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets.Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines.Impact of Adjuvants on the Immunogenicity and Efficacy of Split-Virion H7N9 Vaccine in Ferrets.Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza.Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 challenge without disease enhancement.Increased antibodies against unfolded viral antigens in the elderly after influenza vaccination.
P2860
Q21131612-F5655F04-B34E-49FA-9E1C-66B45C44F1F9Q24601560-16B5053D-7197-44AD-AC59-A9EBA2E81DF4Q24680352-F2DBEBCE-71EE-474B-AD85-222B9F80F6A0Q27301043-40345CEE-DE9D-479D-9DD8-CA34E098E700Q27316330-D5A2D958-DC6A-4A52-8B3E-79B540192585Q27336156-BC2A577A-8D22-46D5-ABF5-BB4F9A448E3BQ27345256-EEEDF520-DB20-4C70-9474-D83B55647F31Q30227975-9F48350A-D4CE-475F-9F40-D98D289B83DEQ30229190-907D2B7C-9D23-4993-AEDF-51B7967B2A7FQ30363581-79CD4A3A-4D66-4672-9293-AEB275E12D8DQ30369679-5E79429F-5596-4C50-8A76-EE9FE2173B99Q30371058-D0928E92-04DE-48C2-AE5F-C055217B8ACEQ30372105-0E7B6F7A-9F31-4FB8-A18D-AC5436FD3F30Q30373784-AC3F2939-C9B6-4B89-BE2A-2FEA69802C73Q30377224-0FF7CED5-1D7B-4453-9357-04796C209985Q30377228-8CA0C96E-B87D-4B6C-A892-C8133A981995Q30377246-0E70BAE4-4178-45BB-A5DF-F227CB496544Q30383623-1298A424-E2B8-442B-B5B8-811A0BF4FD10Q30389924-2FAB73E9-3FFE-47FC-8702-1984C7E7E6E1Q30390753-7F01E2F8-A774-4E98-AE5B-C69EF98B2BA5Q30393616-196147A5-5730-4D0A-A043-E856DD134B81Q30395094-FB6133E9-5729-46F9-87F7-B9012FA352DFQ30398811-7866DD9F-F399-4D26-8AE8-2B8FB32B0290Q30399675-29B6612F-4D33-4C66-A1E9-D58886EF2F79Q30402500-CCBA0221-CB90-407D-861D-A8942AC231F8Q30414652-5E090D21-43BE-4294-B9DA-45ACA11AE956Q30417273-4C3BFE1E-72C0-4815-B119-7DC9050C1284Q30418752-F69B43FB-5F6A-4549-8F9B-3EA9B739BE69Q30420397-9659DCE4-5636-457F-9731-6F4BCF134941Q30420990-AB8FE61E-414C-475E-8288-E5BEABDAE804Q30422513-BB1971F5-EB11-4070-B651-3D24718BD40EQ33396140-5DCF93DB-5DEF-410B-AF80-6B342E2D2BD2Q33624415-446E2C55-5991-482D-ADAE-C7B8A7C77708Q33684287-1CC96F42-AD9C-4FEF-A3AC-704D4630F843Q33931916-6E55E6AB-1E7C-4BA1-A018-24C70302A99EQ35739123-DD52307B-0347-4829-B8F8-9CC14AD96083Q36139178-54D746C9-453C-4161-A24C-52FE99CFF495Q36251479-1CD17CA6-D8B6-4E58-9314-B05A84EAD82BQ36483949-492367B1-AB92-4140-893B-8C19EC65CDB5Q36631961-FA44353B-ED00-4EAA-BC94-70D74A0C5D7B
P2860
Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97
@nl
Cross-protectiveness and immun ...... 203/04(H5N1) virus in ferrets.
@en
type
label
Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97
@nl
Cross-protectiveness and immun ...... 203/04(H5N1) virus in ferrets.
@en
prefLabel
Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97
@nl
Cross-protectiveness and immun ...... 203/04(H5N1) virus in ferrets.
@en
P2093
P356
P1476
Cross-protectiveness and immun ...... 203/04(H5N1) virus in ferrets.
@en
P2093
Aleksandr S Lipatov
Erich Hoffmann
Rachelle Salomon
P304
P356
10.1086/507709
P407
P577
2006-09-12T00:00:00Z